↓ Skip to main content

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease

Overview of attention for article published in Frontiers in Psychiatry, April 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news
2 news outlets
twitter
6 X users

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
159 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
Published in
Frontiers in Psychiatry, April 2018
DOI 10.3389/fpsyt.2018.00091
Pubmed ID
Authors

Wen-Yu Hsu, Hsien-Yuan Lane, Chieh-Hsin Lin

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 159 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 14%
Student > Master 21 13%
Researcher 18 11%
Student > Ph. D. Student 11 7%
Other 8 5%
Other 21 13%
Unknown 57 36%
Readers by discipline Count As %
Medicine and Dentistry 27 17%
Neuroscience 21 13%
Psychology 14 9%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Biochemistry, Genetics and Molecular Biology 8 5%
Other 15 9%
Unknown 65 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2024.
All research outputs
#2,006,947
of 26,490,075 outputs
Outputs from Frontiers in Psychiatry
#1,245
of 13,208 outputs
Outputs of similar age
#40,858
of 347,049 outputs
Outputs of similar age from Frontiers in Psychiatry
#39
of 155 outputs
Altmetric has tracked 26,490,075 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,208 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.7. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,049 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 155 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.